Advertisement
Screener

BRUKER CORPORATION (BRKR) Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Nonredeemable

BRUKER CORPORATION Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Nonredeemable

BRUKER CORPORATION (BRKR) reported Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Nonredeemable of $900.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsNonredeemable · last filed 2026-08-05

  • BRUKER CORPORATION noncontrolling interest in net income (loss) other noncontrolling interests, nonredeemable for the quarter ending 2026-06-30 was $900.00K.
  • BRUKER CORPORATION noncontrolling interest in net income (loss) other noncontrolling interests, nonredeemable for the quarter ending 2026-03-31 was $700.00K, a 133.33% increase year-over-year.
  • BRUKER CORPORATION noncontrolling interest in net income (loss) other noncontrolling interests, nonredeemable for the quarter ending 2025-12-31 was $2.50M.
  • BRUKER CORPORATION noncontrolling interest in net income (loss) other noncontrolling interests, nonredeemable for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
  • BRUKER CORPORATION noncontrolling interest in net income (loss) other noncontrolling interests, nonredeemable for fiscal 2025 was $2.50M.
  • BRUKER CORPORATION noncontrolling interest in net income (loss) other noncontrolling interests, nonredeemable for fiscal 2024 was -$700.00K, a 128.00% decline from fiscal 2023.
  • BRUKER CORPORATION noncontrolling interest in net income (loss) other noncontrolling interests, nonredeemable for fiscal 2023 was $2.50M, a 56.25% increase from fiscal 2022.
  • BRUKER CORPORATION noncontrolling interest in net income (loss) other noncontrolling interests, nonredeemable for fiscal 2022 was $1.60M, a 60.00% increase from fiscal 2021.
Period endNoncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Nonredeemable 3 monthNoncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Nonredeemable 6 monthNoncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Nonredeemable 9 monthNoncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Nonredeemable 12 month
2026-06-30$900.00K
10-Q · filed 2026-08-05
$1.60M
10-Q · filed 2026-08-05
$4.10M
derived: sum of 3 quarters · filed 2026-08-05
$4.10M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$700.00K
10-Q · filed 2026-05-07
$3.20M
derived: sum of 2 quarters · filed 2026-05-07
$3.20M
derived: sum of 3 quarters · filed 2026-05-07
$2.90M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$2.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$2.50M
derived: sum of 2 quarters · filed 2026-02-27
$2.20M
derived: sum of 3 quarters · filed 2026-08-05
$2.50M
10-K · filed 2026-02-27
2025-09-30$0.00
10-Q · filed 2025-11-05
-$300.00K
derived: sum of 2 quarters · filed 2026-08-05
$0.00
10-Q · filed 2025-11-05
-$2.30M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30-$300.00K
10-Q · filed 2026-08-05
$0.00
10-Q · filed 2026-08-05
-$2.30M
derived: sum of 3 quarters · filed 2026-08-05
-$2.00M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$300.00K
10-Q · filed 2026-05-07
-$2.00M
derived: sum of 2 quarters · filed 2026-05-07
-$1.70M
derived: sum of 3 quarters · filed 2026-05-07
-$1.50M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31-$2.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$2.00M
derived: sum of 2 quarters · filed 2026-02-27
-$1.80M
derived: sum of 3 quarters · filed 2026-02-27
-$700.00K
10-K · filed 2026-02-27
2024-09-30$300.00K
10-Q · filed 2025-11-05
$500.00K
derived: sum of 2 quarters · filed 2025-11-05
$1.60M
10-Q · filed 2025-11-05
$1.20M
derived: sum of 4 quarters · filed 2026-02-27
2024-06-30$200.00K
10-Q · filed 2025-08-06
$1.30M
10-Q · filed 2025-08-06
$900.00K
derived: sum of 3 quarters · filed 2026-02-27
$1.20M
derived: sum of 4 quarters · filed 2026-02-27
2024-03-31$1.10M
10-Q · filed 2025-05-07
$700.00K
derived: sum of 2 quarters · filed 2026-02-27
$1.00M
derived: sum of 3 quarters · filed 2026-02-27
$2.30M
derived: sum of 4 quarters · filed 2026-02-27
2023-12-31-$400.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$100.00K
derived: sum of 2 quarters · filed 2026-02-27
$1.20M
derived: sum of 3 quarters · filed 2026-02-27
$2.50M
10-K · filed 2026-02-27
2023-09-30$300.00K
10-Q · filed 2024-11-07
$1.60M
derived: sum of 2 quarters · filed 2024-11-07
$2.90M
10-Q · filed 2024-11-07
$5.00M
derived: sum of 4 quarters · filed 2025-03-03
2023-06-30$1.30M
10-Q · filed 2024-08-09
$2.60M
10-Q · filed 2024-08-09
$4.70M
derived: sum of 3 quarters · filed 2025-03-03
$4.40M
derived: sum of 4 quarters · filed 2025-03-03
2023-03-31$1.30M
10-Q · filed 2024-05-10
$3.40M
derived: sum of 2 quarters · filed 2025-03-03
$3.10M
derived: sum of 3 quarters · filed 2025-03-03
$2.70M
derived: sum of 4 quarters · filed 2025-03-03
2022-12-31$2.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03
$1.80M
derived: sum of 2 quarters · filed 2025-03-03
$1.40M
derived: sum of 3 quarters · filed 2025-03-03
$1.60M
10-K · filed 2025-03-03
2022-09-30-$300.00K
10-Q · filed 2023-11-09
-$700.00K
derived: sum of 2 quarters · filed 2023-11-09
-$500.00K
10-Q · filed 2023-11-09
-$400.00K
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30-$400.00K
10-Q · filed 2023-08-09
-$200.00K
10-Q · filed 2023-08-09
-$100.00K
derived: sum of 3 quarters · filed 2024-02-29
$600.00K
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31$200.00K
10-Q · filed 2023-05-10
$300.00K
derived: sum of 2 quarters · filed 2024-02-29
$1.00M
derived: sum of 3 quarters · filed 2024-02-29
$300.00K
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31$100.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$800.00K
derived: sum of 2 quarters · filed 2024-02-29
$100.00K
derived: sum of 3 quarters · filed 2024-02-29
$1.00M
10-K · filed 2024-02-29
2021-09-30$700.00K
10-Q · filed 2022-11-04
$0.00
derived: sum of 2 quarters · filed 2022-11-04
$900.00K
10-Q · filed 2022-11-04
$3.40M
derived: sum of 4 quarters · filed 2023-03-01
2021-06-30-$700.00K
10-Q · filed 2022-08-05
$200.00K
10-Q · filed 2022-08-05
$2.70M
derived: sum of 3 quarters · filed 2023-03-01
$4.10M
derived: sum of 4 quarters · filed 2023-03-01
2021-03-31$900.00K
10-Q · filed 2022-05-06
$3.40M
derived: sum of 2 quarters · filed 2023-03-01
$4.80M
derived: sum of 3 quarters · filed 2023-03-01
$5.10M
derived: sum of 4 quarters · filed 2023-03-01
2020-12-31$2.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
$3.90M
derived: sum of 2 quarters · filed 2023-03-01
$4.20M
derived: sum of 3 quarters · filed 2023-03-01
$4.00M
10-K · filed 2023-03-01
2020-09-30$1.40M
10-Q · filed 2021-11-05
$1.70M
derived: sum of 2 quarters · filed 2021-11-05
$1.50M
10-Q · filed 2021-11-05
$2.40M
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30$300.00K
10-Q · filed 2021-08-05
$200.00K
10-Q · filed 2021-08-05
$1.00M
derived: sum of 3 quarters · filed 2022-02-28
$1.20M
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31-$100.00K
10-Q · filed 2021-05-10
$700.00K
derived: sum of 2 quarters · filed 2022-02-28
$900.00K
derived: sum of 3 quarters · filed 2022-02-28
$1.80M
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31$800.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
$1.00M
derived: sum of 2 quarters · filed 2022-02-28
$1.90M
derived: sum of 3 quarters · filed 2022-02-28
$1.80M
10-K · filed 2022-02-28
2019-09-30$200.00K
10-Q · filed 2020-11-06
$1.10M
derived: sum of 2 quarters · filed 2020-11-06
$1.00M
10-Q · filed 2020-11-06
2019-06-30$900.00K
10-Q · filed 2020-08-07
$800.00K
10-Q · filed 2020-08-07
2018-12-31$1.30M
10-K · filed 2021-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Avantor, Inc. (AVTR)United States$10.501B-9.72
REVVITY, INC. (RVTY)United States$16.814B53.44
Alamar Biosciences, Inc. (ALMR)United States$2.300B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34